Lensar Stock Loses 48% This Week Despite BTIG Upgrade To Buy

Aditya Raghunath4 minute read
Reviewed by: Thomas Richmond
Last updated Mar 20, 2026

Key Stats for Lensar Stock

  • 5-Day price change for Lensar stock: -48%
  • $LNSR Share Price as of Mar. 19: $6
  • 52-Week High: $15
  • $LNSR Stock Price Target: $13

Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free)>>>

What Happened?

LENSAR (LNSR) stock cratered more than 32% on Tuesday after Alcon terminated its planned acquisition of the medical device company.

Alcon cited two main reasons for walking away: rising costs and regulatory hurdles from the Federal Trade Commission.

For investors who bought in expecting a clean merger close, this was a painful surprise.

LNSR Stock Revenue, EBIT, and EPS Estimates in Billion USD (TIKR)

The timing stings even more given how strong LENSAR’s underlying business has been.

  • In Q4 2024, the company posted record revenue of $16.7 million, up 38% year over year, and
  • placed a record 31 ALLY laser systems in a single quarter.
  • The company also guided for revenue growth above 27% in Fiscal 2024.

See analysts’ growth forecasts and price targets for Lensar stock (It’s free) >>>

What the Market Is Telling Us About Lensar Stock

LENSAR Stock is down almost 50% in the last five days. The selloff wiped out months of stock gains in a matter of days. But not everyone is hitting the panic button.

BTIG upgraded LENSAR stock to buy almost immediately after the drop, setting a price target of $10.

That implies roughly 64% upside from Thursday’s close of $6.11.

Analyst Ryan Zimmerman called the selloff a “second chance” for investors, arguing that the pending deal had actually been slowing the company’s momentum.

With the merger off the table, LENSAR stock can now refocus fully on growing its ALLY platform.

  • ALLY is LENSAR’s flagship adaptive cataract treatment system, and the numbers behind it are compelling.
  • The installed base surpassed 135 systems globally,
  • the company captured nearly 21% U.S. market share in laser cataract procedures, and
  • 75% of new placements in 2024 came from customers brand new to LENSAR.
LNSR Stock Valuation Model (TIKR)

The core business looks healthy.

LENSAR stock is now priced as if the company lost its growth story, when in reality, the deal was the distraction.

For investors willing to look past the noise, this could be exactly the kind of dip worth researching further.

Estimate a company’s fair value instantly (Free with TIKR) >>>

How Much Upside Does Lensar Stock Have From Here?

With TIKR’s new Valuation Model tool, you can estimate a stock’s potential share price in under a minute.

All it takes is three simple inputs:

  1. Revenue Growth
  2. Operating Margins
  3. Exit P/E Multiple

If you’re not sure what to enter, TIKR automatically fills in each input using analysts’ consensus estimates, giving you a quick, reliable starting point.

From there, TIKR calculates the potential share price and total returns under Bull, Base, and Bear scenarios so you can quickly see whether a stock looks undervalued or overvalued.

See a stock’s true value in under 60 seconds (Free with TIKR) >>>

Looking for New Opportunities?

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!

Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.

Sign Up for FREENo credit card required